FIG 3.
Numeric output of specimens tested S+/NC+ on either or both platforms for detection of seroreactivity resulting from prior SARS-CoV-2 infection (n = 1057). (A) Numeric outputs of the two S assays. Gray lines at 0.8 and 1 denote manufacturers’ cutoffs for the Roche and Ortho S assays, respectively. (B) Numeric outputs of the two NC assays. Gray lines at 1 on both axes denote manufacturers’ cutoffs for the respective assays. Blue marks denote S+/NC+ reactive samples on both platforms, yellow marks S+/NC+ on Ortho only, and red marks S+/NC+ on Roche only.